Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
Public ClinicalTrials.gov record NCT05691972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, No-treatment-controlled, Evaluator-blinded, Multi-center Study to Evaluate the Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane® Contour in correction of temple hollowing.
Study identification
- NCT ID
- NCT05691972
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 225 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2023 (Actual)
- Primary completion
- Oct 26, 2023 (Actual)
- Completion
- Dec 11, 2024 (Actual)
- Last update posted
- May 22, 2026
2023 – 2024
United States locations
- U.S. sites
- 15
- U.S. states
- 8
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Research Site | Phoenix | Arizona | 85054 | — |
| Galderma Research Site | Encino | California | 91436 | — |
| Galderma Research Site | Los Angeles | California | 90069 | — |
| Galderma Research Site | Redondo Beach | California | 90277 | — |
| Galderma Research Site | Solana Beach | California | 92075 | — |
| Galderma Research Site | Vista | California | 92083 | — |
| Galderma Research Site | Washington D.C. | District of Columbia | 20037 | — |
| Galderma Research Site | Adventura | Florida | 33180 | — |
| Galderma Research Site | Boynton Beach | Florida | 33437 | — |
| Galderma Research Site | Coral Gables | Florida | 33146 | — |
| Galderma Research Site | New Orleans | Louisiana | 70115 | — |
| Galderma Research Site | New York | New York | 10021 | — |
| Galderma Research Site | Chapel Hill | North Carolina | 27517 | — |
| Galderma Research Site | Wilmington | North Carolina | 28405 | — |
| Galderma Research Site | Nashville | Tennessee | 37203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05691972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 22, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05691972 live on ClinicalTrials.gov.